Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Since the completion of the Human Genome Project, single linear reference genomes (such as GRCh38) have served as the foundation for biomedical research. However, the genetic backgrounds of human ...
I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...
A federally funded study aims to determine if whole-genome sequencing at birth can reduce childhood diseases and deaths while satisfying growing concerns over genetic privacy and public health ...
A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.
Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...
New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...
Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...
New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results